Glutaminase is also reportedly upregulated in response to oncogenes such as c-Myc, Raf, Ras and the Rho GTPase [5–8] and, because of this, glutaminase is an emerging target for cancer therapeutics [7, 9–11]. This evidence concerns the gene GLS and cancer.